After 20 years of working in the pharmaceutical industry scouting active
drugs in research to take to market, along with method transfer to the
manufacturing site, I have learned that there is no such...
Modern advances in pharmacology have resulted in positive benefits for
patients fighting disease, including increased life expectancy and
reduced suffering from disease symptoms. Many of us, our famil...
AnalyteGuru continues its Networking in Science webinar series with
Naiffer Romero, Senior Scientific Affairs Manager, MSc, MPH, United
States Pharmacopeia (USP), on May 24 at 10 a.m. CDT. In this web...
This month the European Medicines Agency (EMA) issued further revisions
to the ever-changing guidance for drug producers when it comes to
nitrosamine testing. In 2018 the Federal Drug Administration (...
Once every now and again a topic hits the headlines in the analytical
world so hard that within a year everybody is talking about the best way
to solve the problem, and the best solutions to use. Ever...
In 2018, medication such as angiotensin II receptor blockers (ARBs) were
found to contain high levels of nitrosamines. Since then, drug
manufacturers have been on a sprint to perform product assessmen...
More than just trace analysis For effective ultra-trace analysis of
nitrosamines in pharmaceuticals you need more than Ninja Stars and
Katanas! Your arsenal should include advanced weaponry, including...
With one massive, global health concern on everyone’s mind these days,
it’s easy to forget that other problems haven’t gone away and may even
be just as important or becoming even more critical. They’...
There are a few Ranitidine (brand name Zantac among others) drug
manufacturers getting heartburn over product recalls at the moment. This
popular generic drug for the treatment of indigestion and refl...